Ranbaxy Q3 profit jumps, beats forecast

Ranbaxy, controlled by Japan’s Daiichi Sankyo, said consolidated net profit stood at ₹ 308 crore ($69.5 million) for the fiscal third-quarter ended September. This compared with ₹ 115 crore reported a year earlier.

A Reuters poll had forecast net profit of ₹ 140 crore for the firm, which is reporting its first quarter of results under a new chief executive who took over in August.

Last month, rival Dr Reddy’s Laboratories Ltd topped estimates with a 32% jump in quarterly profit boosted by strong sales in the domestic market.

Ranbaxy shares, which the market values at $5.7 billion, have risen about 17% so far this year, underperforming the 34% rise in the sector index and the main index’s 19.5% gain.

Milestone Alert!
Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!